Iron Supplements and Gastrointestinal Side Effects

Evidence on Frequency of Side Effects

Nausea rates range from 29-63% in iron-supplemented groups versus 28-65% in control groups, according to the American College of Physicians, with most reported harms being transient and not serious 1, 2
Constipation rates range from 4-29% in iron-supplemented groups versus 1.6-28% in control groups, with the European Society for Clinical Nutrition and Metabolism (ESPEN) confirming that gastrointestinal side effects of iron therapy are not rare 1, 2, 3

The American Gastroenterological Association recommends taking iron once daily rather than multiple times per day to minimize side effects, as increased dosing frequency doesn't improve absorption but significantly increases side effects 4
Alternate-day dosing (every other day) may increase fractional iron absorption and reduce gastrointestinal symptoms while maintaining efficacy, according to the American College of Gastroenterology 4, 5
Taking iron on an empty stomach (1-2 hours before or after meals) is optimal for absorption, but may increase GI symptoms, while taking with small amounts of food may improve tolerability despite reducing absorption 4, 5
The National Institute of Diabetes and Digestive and Kidney Diseases suggests avoiding tea or coffee within one hour of iron administration, as these inhibit absorption 5
Starting with 50-100 mg of elemental iron once daily and limiting elemental iron to no more than 100 mg per day is recommended, especially in patients with GI sensitivity, by the American College of Physicians 4, 5
Taking iron with vitamin C (250-500 mg) may enhance absorption, especially if taking with meals, allowing for lower iron doses while maintaining efficacy, according to the National Institutes of Health 4, 5

Trying a different iron formulation (ferrous gluconate or ferrous fumarate instead of ferrous sulfate) may help, as suggested by the American Society of Hematology 6, 4
Considering ferric maltol, which demonstrates GI side effects comparable to placebo in clinical trials, is an option, according to the European Society for Clinical Nutrition and Metabolism (ESPEN) 5
Switching to intravenous iron if oral iron causes intolerable gastrointestinal symptoms despite dosing adjustments is recommended by the American College of Gastroenterology 4, 5

Iron is listed among medications that commonly cause constipation in cancer patients, alongside opioids, antiemetics, and other agents, according to the European Society for Medical Oncology 7

Constipation is not a prominently reported side effect of naproxen or other NSAIDs in the guideline literature, but NSAIDs like naproxen can cause upper gastrointestinal complications, including a 2.5-5-fold increase in gastrointestinal bleeding and ulceration, as reported by the American Gastroenterological Association 8, 9
NSAIDs are mentioned among drugs that can contribute to constipation in advanced cancer patients, suggesting they may play a contributory role in certain clinical contexts, according to the European Society for Medical Oncology 10

When prescribing iron and naproxen together, anticipate constipation primarily from the iron component, and start prophylactic laxatives when initiating iron supplementation, particularly in elderly patients or those with other constipation risk factors, as recommended by the European Society for Medical Oncology 11, 12
Osmotic laxatives (polyethylene glycol 17g/day, lactulose) or stimulant laxatives (senna, bisacodyl) are preferred first-line options for managing constipation, according to the European Society for Medical Oncology 11
Ensure adequate hydration and dietary fiber intake to minimize constipation risk when taking iron and naproxen, as recommended by the European Society for Medical Oncology 11
Monitor bowel movements closely, particularly in elderly patients who are 5 times more prone to constipation, according to the European Society for Medical Oncology 12

Age is a critical risk factor, with patients over 65 years taking NSAIDs having a 2-3.5-fold increased risk of gastrointestinal complications, and elderly patients being particularly susceptible to constipation from any cause, as reported by the American Gastroenterological Association 8, and the European Society for Medical Oncology 12
Consider gastroprotection with a proton pump inhibitor for the naproxen component, especially in patients over 60 years, as this reduces bleeding ulcer risk by 75-85%, according to the American Gastroenterological Association 8